Virtual Library

Start Your Search

  • ELCC 2017

    The 7th European Lung Cancer Conference

    Access to all presentations that took place at ELCC 2017 in Geneva, Switzerland

    Presentation Date(s):  
    • May 5 – 8, 2017
    • Total Presentations: 359

Filter Results:

Show Only Available Presentations

  • +

    Prevention and smoking cessation

    • Type: Specialty Session
    • Presentations: 5
    • Moderators:P. Boffetta
    • Coordinates: 5/06/2017, 11:00 - 12:30, Room C
    • +

      Smoking and the risk of early lung cancer

      11:00 - 11:20  |  Author(s): H. Ashraf

      • Abstract

      No abstract available for this presentation

    • +

      The environmental factors we should address to reduce the incidence of lung cancer in non-smokers

      11:20 - 11:40  |  Author(s): P. Boffetta

      • Abstract
      • Presentation
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      The e-cigarette: New data with longer follow-up

      11:40 - 12:00  |  Author(s): A. Stoebner-Delbarre

      • Abstract

      No abstract available for this presentation

    • +

      Does smoking cessation improve survival in metastatic lung cancer?

      12:00 - 12:20  |  Author(s): V. Westeel

      • Abstract
      • Presentation
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      Questions and Answers / Panel Discussion

      12:20 - 12:30

      • Abstract

      No abstract available for this presentation

  • +

    Epidemiology and innovations in biomarker development

    • Type: Poster Discussion session
    • Presentations: 12
    • Moderators:P. Boffetta
    • Coordinates: 5/06/2017, 16:45 - 17:45, Room W
    • +

      LBA3 - Correlation between clinical outcomes of patients treated within the tailor trial and next-generation sequencing (NGS) results: Analysis of genes associated to KRAS mutations

      16:45 - 16:45  |  Author(s): M. Ganzinelli

      • Abstract

      Loading...

    • +

      95PD - Diagnostic EGFR testing with ctDNA versus tumour in patients with advanced non-small cell lung cancer (NSCLC): The Royal Marsden experience

      16:45 - 16:45  |  Author(s): R. Kumar

      • Abstract

      Loading...

    • +

      Invited Discussant LBA3 and 95PD

      16:45 - 17:00  |  Author(s): S. Lantuejoul

      • Abstract
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      Discussion

      17:00 - 17:05

      • Abstract

      No abstract available for this presentation

    • +

      30PD_PR - Circulating immune-profile as predictor of outcome in NSCLC patients treated with nivolumab

      17:05 - 17:05  |  Author(s): M. Tiseo

      • Abstract

      Loading...

    • +

      96PD_PR - Evaluation of non-classical response by immune-modified RECIST and efficacy of atezolizumab beyond disease progression in advanced NSCLC: Results from the randomized Phase II study POPLAR

      17:05 - 17:05  |  Author(s): A. Artal-Cortes

      • Abstract

      Loading...

    • +

      Invited Discussant 30PD_PR and 96PD_PR

      17:05 - 17:20  |  Author(s): R..A. Stahel

      • Abstract
      • Presentation
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      Discussion

      17:20 - 17:25

      • Abstract

      No abstract available for this presentation

    • +

      17PD - Patterns of lung cancer metastasis in the US population

      17:25 - 17:25  |  Author(s): M. Hendawi

      • Abstract

      Loading...

    • +

      18PD_PR - Optimal screening interval for detection of newly developed lung cancer: Comparison of sexual difference

      17:25 - 17:25  |  Author(s): M.Y. Kim

      • Abstract

      Loading...

    • +

      Invited Discussant 17PD and 18PD_PR

      17:25 - 17:40  |  Author(s): P. Boffetta

      • Abstract
      • Presentation
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      Discussion

      17:40 - 17:45

      • Abstract

      No abstract available for this presentation